Precision Peptide Company orders 20,000 thymosin alpha-1 patches for launch
The order covers initial commercial supply of a transdermal patch delivering the immune peptide, according to the company.
TR
By Tom Reyes · Markets Editor
Oct 8 08:00 ETSource: Yahoo Finance
The wire
- 01The Precision Peptide Company says it has placed an order for 20,000 thymosin alpha-1 patches ahead of a commercial launch.
- 02Thymosin alpha-1 is normally injected, so a transdermal format would change how clinics and patients handle the immune peptide if it reaches market.
- 03The announcement is a company statement; delivery timing, regulatory status and any data on patch absorption are not detailed.
From the source
Read at finance.yahoo.comRETRANSMISSION: The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch
